-+ 0.00%
-+ 0.00%
-+ 0.00%

AcuCort Lands Order for Zeqmelit Drug in Nordic Market

MT Newswires·12/08/2025 07:31:58
Listen to the news
07:31 AM EST, 12/08/2025 (MT Newswires) -- Swedish biotechnology company AcuCort (ACUC.ST) secured an order worth 112,000 euros for its Zeqmelit drug for the Nordic market. The order for the drug, which is used to treat allergic reactions, croup in children, and nausea and vomiting during chemotherapy, was placed by the company's distribution partner Unimedic Pharma, according to a Monday release.